资讯
Columnist Shalom Lim will continue to pursue the themes that matter to him as a person with Duchenne MD, but as a writer now, ...
Preliminary data are expected this year for a Phase 1/2 clinical trial testing the investigational therapy SRP-1003 in DM1.
Agamree, an approved steroid treatment for Duchenne MD, will be sold in Turkey by GEN, per an agreement with Santhera.
Columnist Robin Stemple, his brothers, and more enjoy a long-in-the works family music celebration at his mother's nursing home.
A protein called MYOD has long been known to be able to turn on genes, but a recent study has found that it also can turn off ...
Enrollment is now ongoing in a first-in-human clinical trial testing EPI-321, a therapy designed to target the underlying ...
Columnist Shalom Lin and his partner, Amanda — both disabled artists — find that their challenges are exactly what can drive ...
Elevidys (delandistrogene moxeparvovec-rokl), previously called SRP-9001, is a onetime gene therapy approved for certain patients with DMD.
Steve Bryson is a science writer for Muscular Dystrophy News with a PhD in biochemistry. He covers the latest news and information on a variety of muscular dystrophy topics.
We all have different tolerance levels for how much risk we'll accept when we do a risk vs. reward analysis, says columnist Patrick Moeschen.
Corticosteroids can slow DMD progression. Understand their benefits, side effects, and how timing impacts long-term treatment outcomes.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果